Is your broker looking out for you? Is your commission really “free”?
Measure broker performance at your finger tips via a cloud-based app.
We provide an easy to navigate interface for all your execution performance needs.

4540 CENTER BOULEVARD
SUITE 1204
LONG ISLAND CITY, NY 11109
United States
Map It

Our NextGen Team has over 25 years experience in Commercial Real Estate and Manufactured Housing Community acquisition funding and operations. Our team specializes in due diligence, financial analysis, acquisition, turn around planning and implementation, and value optimization. We operate in a niche largely overlooked by institutional investors and REITs.
We are Fund Sponsors, Joint Venture Sponsors, and Asset Managers

5633 Strand Blvd
Ste 304
Naples, FL 34110
United States
Map It

Music Royalties Inc. is an artist and investor partnership which provides direct exposure to music revenues from the hyper-growth in global streaming platforms by acquiring song royalties for our shareholders. Our goal is to increase share value by accumulating a diversified portfolio of cash flowing royalties in order to pay increasing dividends.

1805-55 University Ave
Ontario Toronto
Canada
Map It

We finance manufactured homes in select Arizona and Nevada communities. We have developed a rating system much like the way we were graded in school, A, B, C, D and F to rate communities. We finance homes in A & B rated communities.

Why only A&B communities and not others? it’s all about maintaining home values. Homes in the nicer communities sell for more and maintain their value. People want to live in the nicer communities.

15508 W Bell Rd. Ste 101 #519
Arizona Surprise
United States
Map It

Avrika Life is a meticulously acutely focused bio tech entity that accelerates deeply complex acculturated scientific research with evocative biotic diversity solutions.

Avrika Life innovations include a -91% reduction with chemical use in disinfectants with a+1,020% higher efficacy, with a 99.999% kill rate. Avrika Life’s disinfectant technology is the first break through cleaning formulation in the last 107 years, thus rendering all 4,569 EPA approved disinfectant products as obsolete.

Avrika’s Life Nature Lock technology extends the life of almost all food products by +28 to +52% longer freshness and consumption. Nature Lock eliminates up to 60% of all carbon emissions caused by food waste. Avrika Life Nature Lock is a completely benign harmless solution for human and animal consumption with proven technology.

Avrika Life technology eliminates up to 175 viruses, bacteria, fungus and other diseases with significantly transformative research led by a very highly acclaimed scientific team, including four scientists mentored by Nobel Prize recipients, and a Oxford Rolls Royce Fellow.

Avrika Life drives energy, water and land costs with an environmental rebalance of all natural resources that exceeds over $1T with less consumptive food waste of $5.6T annually.

Avrika Life is developing Spark Innovation research facility centers in Singapore, Overland Park and Cambridge-Oxford, UK.

For more details contact Tom Johnson
(UHNWI, or UHNWF groups, only please).

11750 West 135th Street
Suite 101
Overland Park, KS 66221
United States
Map It

I provide operations management and support to in-house Single- and Multi-Family Office teams, helping them grow, run more effectively, report more quickly, and turn around problems quickly. Reporting can even be near-real-time with the right software and feeds. There will always be some manual entries, and the objective would be to automate as much as possible.

My services can be part- or full-time, short- or long-term, and remote. We are located about 50 mi West of New York City.

See the Managing Director page on my website.

7 Meadow Rose Ct
Hackettstown, NJ 07840-3142
United States
Map It

Founded in 2018, Palindrome LLP primarily operates in the Inland Northwest with plans and capacity to expand to regional markets throughout the United States. We invest in established businesses across a broad set of industries that possess a combination of compelling value, ownership tenure, and consistency of cash flows. Our value discipline, broad industry diversification, and experienced team reinforces this strategy.

Our process is simple. We look for companies with decades of demonstrated success and talented teams. Then we listen and we learn – in search of shared values, a sustainable business model, and the opportunity to develop a partnership.

We aim to create long-term value for our partners and portfolio companies by providing support in accounting, operational, and personnel functions to promote growth while simultaneously preserving legacy and culture. We understand that capital alone will not determine our long-term success and we take pride in putting people first throughout our process.

9 South Washington Street
Suite 515
Spokane, Washington 99201
United States
Map It

Vaulted is a fintech approach to acquiring physical, allocated, and deliverable ounces of gold. With its reshaping of the supply chain, favorable tax advantages, and lowest spreads, Vaulted is the most cost effective way to own real gold anywhere in the world. It has 24 hour settlements and assigned advisors and yet can be a fully autonomous tool. McAlvany ICA is a brokerage firm founded in 1972 specializing in compounding ounce strategies, IRA’s, and international storage accounts, providing access to silver, platinum, and palladium – in addition to gold.

166 Turner Drive
Durango, CO 81303
United States
Map It

Aphios® Pharma is developing FDA-approved, cannabis-based drugs for treating highly unmet central and peripheral nervous system disorders of opioid addiction, pain, anxiety, epilepsy and Multiple Sclerosis that are only partially and anecdotally addressed by medical marijuana.

Aphios® Pharma is dedicated to the delivery, development and commercialization of cannabis-based drugs for CNS and other debilitating disorders. We will manufacture and utilize pharmaceutical-grade pure natural cannabinoids in stable, bioavailable nanoformulations, following cGMP guidelines of the FDA and Schedule 1 requirements of the Drug Enforcement Administration (DEA). These cannabinoid nanoformulations will be used to establish clinical evidence for treating highly unmet central and peripheral nervous system disorders such as chronic pain, cancer induced peripheral neuropathic pain, opioid and substance use disorders, anxiety, epilepsy and Multiple Sclerosis that are only partially and anecdotally addressed by medical marijuana.

Apart from the recent FDA approval of Epidiolex (GW Pharma, London, England) for specific cases of childhood epilepsy, there is little rigorous clinical evidence of the efficacy of cannabinoids for significant peripheral and central nervous system neurological disorders, and lack of availability of pharmaceutical-grade cannabinoids to conduct rigorous clinical studies. These issues are compounded by a prohibitive DEA, NIH and FDA regulatory environment for developing FDA-approved, cannabis-based drugs. From a technical perspective, cannabinoids are very hydrophobic (poorly water soluble) making formulation difficult and bioavailability poor; also, cannabinoids are very oxygen sensitive and unstable, contributing to inconsistencies in therapeutic performance. After FDA approval of Epidiolex, Jazz Pharmaceuticals acquired GW Pharma for $7.2 billion.

We plan to initially develop, in compliance with the DEA, FDA-approved cannabinoid nanotherapeutics that target CIPNP and opioid use disorder. Later, we plan to develop cannabinoid nanotherapeutics that target anxiety, epilepsy and Multiple Sclerosis.

469 Mystic Street
87 Main Street
North Reading, MA 01864
United States
Map It